April 3, 2009

Advisory panel recommendations for expanded marketing approval are usually followed by the FDA.  Philadelphia Inquirer journalist, Miriam

Read More
Conflicts for FDA committee set to weigh risks of Seroquel_Philadelphia Inquirer